Nav: Home

Free lung cancer screening program builds valuable relationships with patients

January 24, 2019

Augusta, Ga. (Jan. 24, 2019) - A free, simple screening for lung cancer can save a patient money, while building a healthy relationship for any medical needs they may have in the future. The research, published in the Annals of Thoracic Surgery, shows the partnership can be beneficial for patients looking for cardiology specialists, family medical care and other health-related issues, as well as for medical facilities that offer the free screening.

"Our mission is to find lung cancer earlier," said Dr. Carsten Schroeder, thoracic surgical oncologist at the Georgia Cancer Center and Medical College of Georgia at Augusta University. "If we find a nodule in the lung that's in the later stages, survival rate is much worse than if we find it earlier."

In the paper, titled "Financial analysis of free lung cancer screening shows profitability using broader NCCN Guidelines," Schroeder and his team analyzed fiscal years 2015-17 to evaluate indirect cost, direct cost and adjusted net margin per case after factoring downstream revenue from treating patients with positive scans and other findings.

"In all, we have 1,600 people on the screening list," Schroeder said. "Of those, 1,200 have actually had a scan. In just over 2 percent of those patients, we found lung cancer. The remaining 400 people do not meet the necessary criteria."

The idea to develop the free lung screen program started after a major research paper was published in the summer of 2011. The National Cancer Institute's National Lung Screening Trial, which included 50,000 people, showed a computerized tomography (CT) screening is better than chest x-ray for screening for lung cancer.

"There was a 20 percent increase in the survival rate for those patients who had the CT screening," Schroeder said. "This paper was the one that served as a catalyst for the Centers for Medicare and Medicaid Services to start covering the cost of the screening for patients."

While patients do not need to have health insurance to qualify for the lung screening program, there are some criteria they must meet, including:

Group 1:
  • 55-75 years old.

  • Currently a smoker or have quit within the past 15 years.

  • Smoked at least a pack of cigarettes a day for 30+ years.

Group 2:
  • 50-75 years old.

  • Smoked at least a pack of cigarettes a day for 20+ years.

  • Have at least one of the following additional lung cancer risks:
    • Personal cancer history (lung, head and neck, lymphoma).

    • Family history -- parent, sibling or child -- of lung cancer.

    • Emphysema or chronic bronchitis.

    • Chronic Obstructive Pulmonary Disease (COPD).

    • Long-term exposure to asbestos.

    • Asbestos-related lung disease or pulmonary asbestosis.

    • Long term exposure to silica, cadmium, arsenic, beryllium, chromium, diesel fumes, nickel, radon, uranium or coal smoke and soot.

For his research, Schroeder and his team looked at the costs from a total of 705 scans. Of that 705, 418 patients were referred for follow-up procedures and specialist evaluations. The adjusted net margin per case was -$212 in the first year but turned positive to $177 in the third fiscal year.

One major factor influencing the profitability of a free screening, is the ability to use the National Comprehensive Cancer Network (NCCN) guidelines, which covers Group 2 of eligible patients. Currently, no other hospitals or medical centers in Augusta's River Region can use NCCN guidelines because they charge patients for a lung screening. Using the NCCN guidelines allowed Schroeder and his team to detect twice the number of lung cancers than if they had only screened Group 1.

"Our free lung screening program is a win for the communities we serve and for the hospital system," Schroeder said. "We bring them in for a free screening, which serves as a starting point for their medical care and health needs for the rest of their lives."
-end-


Medical College of Georgia at Augusta University

Related Lung Cancer Articles:

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.
Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.
Better equipped in the fight against lung cancer
Lung cancer is the third most common type of cancer in Germany and the disease affects both men and women.
New liquid biopsy-based cancer model reveals data on deadly lung cancer
Small cell lung cancer (SCLC) accounts for 14 percent of all lung cancers and is often rapidly resistant to chemotherapy resulting in poor clinical outcomes.
Cancer drug leads to 'drastic decrease' in HIV infection in lung cancer patient
Doctors in France have found the first evidence that a cancer drug may be able to eradicate HIV-infected cells in humans.
Air pollution is associated with cancer mortality beyond lung cancer
A large scale epidemiological study associates some air pollutants with kidney, bladder and colorectal cancer death.
More Lung Cancer News and Lung Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.